Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2023-05, Vol.201 (3), p.568-572
Hauptverfasser:	Wang, Huafeng, Yao, Yiyi, Mao, Liping, Lou, Yinjun, Ren, Yanling, Ye, Xingnong, Yang, Min, Ma, Liya, Zhang, Yi, Zhou, Yile, Wu, Jiaying, Huang, Xin, Wang, Yungui, Xu, Huan, Tong, Hongyan, Zhu, Hong‐Hu, Jin, Jie
Format:	Artikel
Sprache:	eng
Schlagworte:	acute myeloid leukaemia Acute myeloid leukemia Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Chemotherapy Cytarabine Cytarabine - therapeutic use Daunorubicin Daunorubicin - therapeutic use DAV efficacy Hematology Humans Leukemia, Myeloid, Acute - etiology Remission Induction Retrospective Studies safety venetoclax
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!